Reshape Lifesciences Inc (RSLS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1.92% 1.944	1.982	2.155	2.254	2.287
Cost Of Revenue	456.43% 0.779	0.14	0.867	1.06	1.063
Gross Profit	36.75% 1.165	1.842	1.288	1.194	1.224
Operating Expenses	9.69% 3.375	3.737	5.168	5.17	6.855
Benefits Costs and Expenses	12.99% 4.123	3.649	5.686	5.743	4.935
Costs And Expenses	12.99% 4.123	3.649	5.686	5.743	4.935
Operating Income/Loss	16.62% -2.21	-1.895	-3.88	-3.976	-5.631
Income/Loss From Continuing Operations Before Tax	30.71% -2.179	-1.667	-3.531	-3.489	-2.648
Income Tax Expense/Benefit, Deferred	96.30% 0.001	0.027	0.002	-	-0.001
Income Tax Expense/Benefit	54.84% 0.014	0.031	0.003	0.004	0.014
Income/Loss From Continuing Operations After Tax	29.15% -2.193	-1.698	-3.534	-3.493	-2.662
Net Income/Loss	29.15% -2.193	-1.698	-3.534	-3.493	-2.662
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	645.43% 23.46	3.1468	3.4527	3.2493	1.7081
Diluted Average Shares	645.43% 23.46	3.1468	3.4527	3.2493	1.7081
Basic Earnings Per Share	105.84% -0.09	1.54	-1.02	-1.08	-1.56
Diluted Earnings Per Share	105.84% -0.09	1.54	-1.02	-1.08	-1.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$217.09

1.38%

ZBH

$113.02

0.43%

PHG

$25.95

0.43%

DXCM

$76.27

0.51%

GEHC

$82.72

1.17%

$69.89

3.14%